Sabra Health Care REIT, Inc. Financial Ratios — SBRA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	2.34	3.23	2.9	3.5	2.97	3.41	4.07	1.08	2.3	-1.9	-1.32	0.25	2.37	2.88
Return on Capital (%)	- -	12.13	12.97	11.76	12.44	11.89	11.46	13.41	7.66	13.18	- -	- -	12.28	37.01	47.93
Return on Invested Capital (%)	- -	6.94	8.18	6.91	6.4	6.9	4.94	4.49	5.17	4.31	- -	- -	3.57	4.88	4.94
Gross Margin (%)	100	100	100	98.95	98.92	97.81	95.63	92.05	83.61	78.02	75.21	73.97	69.85	67.71	65
EBITDA Margin (%)	82.82	84.39	87.81	84.01	86.81	88.9	83.5	79.83	78.75	72.24	68.43	67.64	62.52	60.59	58.2
Operating Margin (%)	51.24	55.06	63.12	60.4	60.4	62.62	55.61	49.14	51.32	42.71	37	37.59	34.24	36.47	34.06
Incremental Operating Margin (%)	- -	72.01	89.44	52.88	60.4	87.07	43.24	36.86	86.82	132.86	154.77	43.59	-57.84	62.36	10.38
Pretax Margin (%)	15.25	18.91	25.01	25.56	33.55	27.35	38.95	45.26	10.94	23.24	-19.56	-12.22	2.43	18.16	20.31
Profit Margin (%)	15.25	18.91	25.01	25.58	33.25	26.97	38.79	44.77	10.43	23.12	-19.89	-12.42	2.12	18.02	20.09
Net Income to Common Margin (%)	15.25	18.91	19.1	20	28.96	23.04	36.28	43.2	10.43	23.12	-19.89	-12.42	2.12	18.02	20.09
Effective Tax Rate (%)	- -	- -	- -	- -	0.93	1.47	0.41	1.07	4.7	0.51	- -	- -	12.7	0.79	1.17
Dvd Payout Ratio (%)	246.38	250.75	194.9	194.54	144.2	182.03	116.03	117.1	485.86	201.06	-232.15	-357.14	2,016.92	221.09	186.28
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	379	575	691	1,091	1,380	1,211	3,493	3,316	2,472	2,430	2,444	2,549	2,447	2,444	2,550
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	197	94	107	218
LT Debt	379	575	691	1,091	1,380	1,211	3,493	3,316	2,472	2,430	2,444	2,352	2,352	2,338	2,333
Total Debt/EBITDA	5.43	6.61	5.84	7.08	6.65	5.23	10.24	6.66	4.74	5.62	6.27	6.03	6.04	5.74	5.66
Net Debt/EBITDA	4.83	6.41	5.8	6.68	6.62	5.12	8.44	6.39	4.53	5.35	5.86	5.81	5.86	5.53	5.45
Total Debt/EBIT	8.78	10.13	8.12	9.85	9.56	7.42	15.38	10.82	7.28	9.5	11.6	10.85	11.04	9.53	9.67
Net Debt/EBIT	7.8	9.83	8.07	9.29	9.51	7.26	12.67	10.39	6.96	9.05	10.83	10.46	10.7	9.19	9.31
EBITDA to Interest Expense	2.3	2.54	2.93	3.28	3.5	3.57	3.85	3.38	4.12	4.31	3.95	4.01	3.58	3.7	4.01
EBITDA-CapEx/Interest Expense	-4.44	2.54	2.93	3.28	3.5	3.57	3.85	3.38	4.12	4.31	3.95	4.01	3.58	3.7	4.01
EBIT to Interest Expense	1.42	1.65	2.1	2.36	2.44	2.51	2.57	2.08	2.68	2.55	2.14	2.23	1.96	2.22	2.35
Interest Expense	30	34	40	47	59	65	88	147	127	100	99	105	113	115	112
Common Equity/Total Assets	-2.46	-5.28	-6.35	-5.34	-5.73	-8.45	-3.06	-4.05	-9.41	-11.93	-18.32	-25.22	-31.86	-35.3	-36.61
Long-Term Debt/Equity (%)	116.04	188.38	150.21	115.87	130.92	119.21	101.61	101.87	70.86	71.28	72.32	76.95	83.93	85.29	82.61
Long-Term Debt/Capital (%)	105.11	109.18	112.08	111.24	111.41	118.78	106.43	108.7	130.05	141.61	180.88	213.94	321.92	408.56	430.89
Long-Term Debt/Total Assets (%)	50.55	62.77	58.9	52.85	55.89	53.43	49.66	49.75	40.73	40.6	40.96	40.92	43.67	44.08	42.46
Total Debt/Equity (%)	116.04	188.38	150.21	115.87	130.92	119.21	101.61	101.87	70.86	71.28	72.32	83.4	87.3	89.17	90.31
Total Debt/Capital (%)	105.11	109.18	112.08	111.24	111.41	118.78	106.43	108.7	130.05	141.61	180.88	231.86	334.85	427.18	471.08
Total Debt/Total Assets (%)	50.55	62.77	58.9	52.85	55.89	53.43	49.66	49.75	40.73	40.6	40.96	44.35	45.42	46.09	46.42
Net Debt to Equity	103.1	182.79	149.28	109.31	130.22	116.68	83.67	97.76	67.74	67.85	67.54	80.4	84.67	85.99	87.02
Net Debt/Capital (%)	105.79	109.48	112.16	111.99	111.48	119.27	104.09	106.06	126.93	139.61	184.18	234.03	344.19	460.59	523.03
EBITDA	70	87	118	154	207	232	341	498	521	432	390	423	405	426	451
EBITDA-CapEx	-135	87	118	154	207	232	341	498	521	432	390	423	405	426	451
Operating Income (Loss)	43	57	85	111	144	163	227	306	340	256	211	235	222	256	264

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.96	0.48	0.19	1.94	0.21	0.65	5.06	0.53	0.36	0.4	0.78	0.15	0.18	0.27	0.21
Current Ratio	1.6	1.83	3.28	5.27	3.67	3.37	7.38	2.39	1.83	1.55	1.78	0.59	0.78	0.88	0.56
Quick Ratio	0.96	0.81	8.18	9.35	7.89	3.15	6.71	2.29	1.74	1.5	1.75	0.58	0.76	0.86	0.54
CFO/Avg Current Liab	- -	1.41	2.14	3.16	3.62	4.7	1.91	3.65	3.66	2.78	2.46	1.31	1.05	1.36	1.24
Common Equity/Total Assets	-2.46	-5.28	-6.35	-5.34	-5.73	-8.45	-3.06	-4.05	-9.41	-11.93	-18.32	-25.22	-31.86	-35.3	-36.61
Long-Term Debt/Equity (%)	116.04	188.38	150.21	115.87	130.92	119.21	101.61	101.87	70.86	71.28	72.32	76.95	83.93	85.29	82.61
Long-Term Debt/Capital (%)	105.11	109.18	112.08	111.24	111.41	118.78	106.43	108.7	130.05	141.61	180.88	213.94	321.92	408.56	430.89
Long-Term Debt/Total Assets (%)	50.55	62.77	58.9	52.85	55.89	53.43	49.66	49.75	40.73	40.6	40.96	40.92	43.67	44.08	42.46
Total Debt/Equity (%)	116.04	188.38	150.21	115.87	130.92	119.21	101.61	101.87	70.86	71.28	72.32	83.4	87.3	89.17	90.31
Total Debt/Capital (%)	105.11	109.18	112.08	111.24	111.41	118.78	106.43	108.7	130.05	141.61	180.88	231.86	334.85	427.18	471.08
Total Debt/Total Assets (%)	50.55	62.77	58.9	52.85	55.89	53.43	49.66	49.75	40.73	40.6	40.96	44.35	45.42	46.09	46.42
CFO/Total Liabilities	10.57	9.2	8.7	7.6	8.56	14.07	3.78	10.57	14.43	13.77	13.78	11.73	11.63	12.12	13.06
CFO/CapEx	0.22	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	0.83	1.07	1.14	1.02	0.79	1.05	0.57	0.73	1.11	0.92	0.67	0.5	0.56	0.74	0.78

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	5.26	3.05	3.71	4.17	3.85	3.81	4.37	4.6	5.3	6.37
Days Sales Outstanding	- -	- -	- -	- -	- -	69.37	119.76	98.38	87.59	94.85	95.73	83.54	79.4	68.92	57.26
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	0.07	0.08	0.15	0.25	0.5	2.29	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	5,106.6	4,743.65	2,394.32	1,452.66	726.93	159.54	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	-5,106.6	-4,743.65	-2,324.95	-1,332.91	-628.55	-71.95	94.85	95.73	83.54	79.4	68.92	57.26
Inventory to Cash Days	- -	- -	- -	- -	- -	69.37	119.76	98.38	87.59	94.85	95.73	83.54	79.4	68.92	57.26
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	364	805	981	1,408	1,259	1,594	1,983	2,938	3,994	3,582	2,966	2,871	3,299	4,044	4,570
- Cash & Cash Equivalents	42	17	4	62	7	26	519	50	39	59	112	49	41	60	72
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	4	4	- -	- -	- -	- -	- -	- -	2
+ Total Debt	379	575	691	1,091	1,380	1,211	3,493	3,316	2,472	2,430	2,444	2,549	2,447	2,444	2,550
Enterprise Value	701	1,363	1,668	2,437	2,632	2,779	4,961	6,208	6,427	5,953	5,298	5,370	5,705	6,428	7,051
Total Capital	361	527	617	981	1,238	1,019	3,282	3,050	1,901	1,716	1,351	1,099	731	572	541
Total Debt/Capital (%)	105.11	109.18	112.08	111.24	111.41	118.78	106.43	108.7	130.05	141.61	180.88	231.86	334.85	427.18	471.08
Total Debt / EV	0.54	0.42	0.41	0.45	0.52	0.44	0.7	0.53	0.38	0.41	0.46	0.47	0.43	0.38	0.36
EV/Sales	8.32	13.21	12.37	13.28	11.02	10.67	12.15	9.96	9.71	9.95	9.3	8.6	8.81	9.14	9.1
EV/EBITDA	10.05	15.66	14.09	15.81	12.69	12	14.55	12.47	12.33	13.77	13.59	12.71	14.09	15.09	15.64
EV/EBIT	16.23	24	19.6	21.99	18.24	17.04	21.85	20.27	18.93	23.28	25.14	22.87	25.73	25.07	26.72
EV/Cash Flow to Firm	9.34	15.05	16.26	18.42	14.64	11.59	22.16	12.27	13.03	13.09	11.6	12.7	14.29	15.13	15.34
EV/Free Cash Flow to Firm	2.51	15.05	16.26	18.42	14.64	11.59	22.16	12.27	13.03	13.09	11.6	12.7	14.29	15.13	15.34
Diluted Market Cap	365	811	995	1,424	1,264	1,600	1,987	2,945	4,015	3,600	2,966	2,871	3,322	4,088	4,631
Diluted Enterprise Value	701	1,369	1,682	2,454	2,636	2,785	4,965	6,215	6,448	5,971	5,298	5,370	5,727	6,472	7,111
EV per Share	23.27	36.79	44.45	52.58	42.28	42.57	46.97	34.82	34.34	28.87	24.19	23.25	24.67	27.53	29.22
TTM Sales	84	103	135	184	239	261	408	623	662	599	570	625	648	703	775
TTM EBITDA	70	87	118	154	207	232	341	498	521	432	390	423	405	426	451
TTM Operating Income	43	57	85	111	144	163	227	306	340	256	211	235	222	256	264
TTM Cash Flow to Firm	75	91	103	132	180	240	224	506	493	455	457	423	399	425	460
TTM Free Cash Flow to Firm	280	91	103	132	180	240	224	506	493	455	457	423	399	425	460

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	1.46	14.41	16.03	16.69	10.43	9.09	14.63	8.17	10.78	10.15	8.32	9.09	11.05	13.17	13.28
EV/EBIT	16.23	24	19.6	21.99	18.24	17.04	21.85	20.27	18.93	23.28	25.14	22.87	25.73	25.07	26.72
Enterprise Value	701	1,363	1,668	2,437	2,632	2,779	4,961	6,208	6,427	5,953	5,298	5,370	5,705	6,428	7,051
Low Price	7.86	11.91	21.55	24.01	18.16	14.92	18.48	15.7	15.88	5.55	12.31	11.44	10.08	12.83	15.6
EV/Sales	8.32	13.21	12.37	13.28	11.02	10.67	12.15	9.96	9.71	9.95	9.3	8.6	8.81	9.14	9.1
EV/EBITDA	10.05	15.66	14.09	15.81	12.69	12	14.55	12.47	12.33	13.77	13.59	12.71	14.09	15.09	15.64
Price/Earnings	28.35	41.25	38.08	38.35	18.2	26.56	13.38	10.91	57.89	25.88	- -	- -	239.84	31.92	29.37
Price/Earnings Average	34.12	33.56	38.3	35.3	24.1	23.65	16.77	13.24	55.78	23.16	-32.09	-40.62	213.36	29.19	27.87
Price/Earnings High	45.27	43.42	47.2	39.57	30.99	28.71	20.75	15.78	67.68	33.6	-36.79	-49.4	249.09	36.91	30.97
Price/Earnings Low	18.43	22.62	31.4	30.32	16.34	16.22	13.18	10.39	43.08	8.27	-23.81	-34.04	169.42	23.64	24.19
Price/Book Value	-19.76	-16.64	-13.16	-12.77	-8.9	-8.32	-9.2	-10.89	-6.99	-5.02	-2.71	-1.98	-1.92	-2.16	-2.27
Price/Book Value Average	-23.79	-13.54	-13.23	-11.75	-11.78	-7.41	-11.53	-13.22	-6.74	-4.49	-3.33	-2.17	-1.71	-1.98	-2.16
Price/Book Value High	-31.56	-17.51	-16.31	-13.18	-15.15	-9	-14.27	-15.75	-8.18	-6.51	-3.81	-2.64	-2	-2.5	-2.4
Price/Book Value Low	-12.85	-9.12	-10.85	-10.09	-7.99	-5.09	-9.06	-10.38	-5.2	-1.6	-2.47	-1.82	-1.36	-1.6	-1.87
Price/Tangible Book Value	1.11	2.64	2.13	1.49	1.19	1.61	0.61	0.94	1.18	1.08	0.89	0.95	1.19	1.49	1.66
Price/Tangible Book Value Average	1.34	2.14	2.14	1.38	1.58	1.44	0.76	1.14	1.14	0.96	1.09	1.05	1.06	1.36	1.57
Price/Tangible Book Value High	1.78	2.77	2.64	1.54	2.03	1.74	0.94	1.36	1.38	1.4	1.25	1.27	1.24	1.72	1.75
Price/Tangible Book Value Low	0.72	1.44	1.76	1.18	1.07	0.98	0.6	0.9	0.88	0.34	0.81	0.88	0.84	1.1	1.36
Price/Sales	4.32	7.8	7.28	7.67	5.27	6.12	4.86	4.71	6.04	5.98	5.21	4.59	5.1	5.75	5.9
Price/Sales Average	5.2	6.35	7.32	7.06	6.98	5.45	6.09	5.72	5.82	5.36	6.38	5.05	4.53	5.26	5.6
Price/Sales High	6.9	8.21	9.02	7.92	8.97	6.62	7.53	6.82	7.06	7.77	7.32	6.14	5.29	6.65	6.22
Price/Sales Low	2.81	4.28	6	6.06	4.73	3.74	4.78	4.49	4.49	1.91	4.73	4.23	3.6	4.26	4.86
Price/Cash Flow	8.14	14.31	15.79	16.5	10.4	9.06	14.6	8.15	10.72	10.09	8.32	9.09	10.98	13.02	13.11
Price/Cash Flow Average	9.8	11.64	15.88	15.18	13.76	8.07	18.3	9.89	10.33	9.03	10.2	9.98	9.76	11.91	12.44
Price/Cash Flow High	13.01	15.06	19.57	17.02	17.7	9.8	22.63	11.78	12.54	13.11	11.69	12.14	11.4	15.06	13.82
Price/Cash Flow Low	5.29	7.85	13.02	13.04	9.33	5.54	14.37	7.76	7.98	3.23	7.57	8.37	7.75	9.65	10.8
Price/Free Cash Flow Average	1.76	11.72	16.12	15.36	13.81	8.1	18.33	9.91	10.39	9.08	10.2	9.98	9.83	12.04	12.61
Price/Free Cash Flow High	2.34	15.17	19.86	17.22	17.76	9.83	22.68	11.81	12.6	13.17	11.69	12.14	11.48	15.23	14.01
Price/Free Cash Flow Low	0.95	7.9	13.21	13.19	9.37	5.56	14.4	7.78	8.02	3.24	7.57	8.37	7.81	9.75	10.94
EV/Sales Average	9.2	11.76	12.41	12.67	12.72	10	13.38	10.97	9.49	9.32	10.48	9.05	8.25	8.65	8.8
EV/Sales High	10.9	13.62	14.12	13.53	14.72	11.16	14.82	12.06	10.73	11.73	11.41	10.14	9.01	10.04	9.42
EV/Sales Low	6.81	9.69	11.1	11.67	10.48	8.29	12.08	9.74	8.17	5.87	8.83	8.23	7.31	7.65	8.06
EV/EBITDA Average	11.11	13.94	14.14	15.08	14.66	11.25	16.02	13.74	12.05	12.9	15.31	13.37	13.19	14.28	15.12
EV/EBITDA High	13.16	16.14	16.07	16.1	16.96	12.56	17.75	15.11	13.63	16.24	16.68	14.99	14.41	16.57	16.19
EV/EBITDA Low	8.22	11.48	12.63	13.9	12.07	9.32	14.46	12.19	10.37	8.13	12.9	12.17	11.7	12.63	13.85
EV/EBIT Average	17.95	21.36	19.67	20.98	21.07	15.97	24.06	22.32	18.5	21.81	28.31	24.07	24.09	23.72	25.84
EV/EBIT High	21.27	24.75	22.36	22.39	24.37	17.83	26.66	24.55	20.92	27.46	30.84	26.97	26.3	27.53	27.66
EV/EBIT Low	13.28	17.6	17.58	19.33	17.35	13.24	21.72	19.81	15.92	13.75	23.86	21.89	21.36	20.98	23.67
Last Price	12.09	21.72	26.14	30.37	20.23	24.42	18.77	16.48	21.34	17.37	13.54	12.43	14.27	17.32	18.94
High Price	19.31	22.86	32.4	31.34	34.44	26.4	29.1	23.83	24.95	22.55	19.02	16.6	14.82	20.03	19.97
Enterprise Value Average	775	1,213	1,673	2,325	3,039	2,605	5,463	6,836	6,282	5,577	5,967	5,652	5,340	6,083	6,818
Enterprise Value High	918	1,406	1,902	2,482	3,516	2,909	6,052	7,519	7,103	7,021	6,499	6,333	5,832	7,061	7,300
Enterprise Value Low	573	1,000	1,495	2,142	2,503	2,159	4,930	6,069	5,405	3,516	5,029	5,142	4,736	5,380	6,245

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	37	37	39	59	65	65	178	178	205	211	230	231	231	238	252
Diluted Weighted Avg Shares	30	37	38	47	62	66	106	179	188	207	219	231	233	236	244
Basic Weighted Avg Shares	30	37	38	46	62	65	106	178	187	206	219	231	231	233	241
Revenue per Share	2.8	2.78	3.59	3.96	3.84	3.99	3.87	3.5	3.54	2.9	2.6	2.71	2.8	3.01	3.21
EBITDA per Share	2.32	2.35	3.15	3.33	3.33	3.55	3.23	2.79	2.78	2.1	1.78	1.83	1.75	1.82	1.87
Operating Income per Share	1.43	1.53	2.27	2.39	2.32	2.5	2.15	1.72	1.81	1.24	0.96	1.02	0.96	1.1	1.09
Basic EPS, GAAP	0.43	0.53	0.69	0.79	1.11	0.92	1.4	1.51	0.37	0.67	-0.52	-0.34	0.06	0.54	0.64
Basic EPS from Cont Ops	0.43	0.53	0.9	1.01	1.28	1.08	1.5	1.57	0.37	0.67	-0.52	-0.34	0.06	0.54	0.64
Diluted EPS, GAAP	0.43	0.52	0.68	0.78	1.11	0.92	1.4	1.51	0.37	0.67	-0.52	-0.34	0.06	0.54	0.64
Diluted EPS from Cont Ops	0.43	0.52	0.89	1	1.27	1.07	1.5	1.56	0.37	0.67	-0.52	-0.34	0.06	0.54	0.64
Dividend per Share	1.05	1.32	1.55	1.76	1.77	1.83	1.72	1.82	1.79	1.35	1.2	1.2	1.2	1.2	1.2
Cash Flow per Share	1.48	1.52	1.66	1.84	1.95	2.69	1.29	2.02	1.99	1.72	1.63	1.37	1.3	1.33	1.44
Free Cash Flow per Basic Share	-5.31	1.52	1.66	1.84	1.95	2.69	1.29	2.02	1.99	1.72	1.63	1.37	1.3	1.33	1.44
Cash & Equivalents per Share	1.4	0.46	0.11	1.33	0.12	0.39	4.91	0.28	0.21	0.29	0.51	0.21	0.18	0.26	0.3
Book Value per Share	-0.61	-1.31	-1.99	-2.38	-2.27	-2.93	-2.04	-1.51	-3.05	-3.46	-4.99	-6.28	-7.42	-8.02	-8.33
Tangible Book Value per Share	10.85	8.24	12.26	20.32	16.93	15.15	30.96	17.52	18.1	16.13	15.18	13.06	11.99	11.62	11.43

Sabra Health Care REIT, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)